Compliance With FDA Nicotine Warning Statement Provisions in E-liquid Promotion Posts on Instagram | Zendy

Linnea Laestadius | Zendy; Megan M. Wahl | Zendy; Julia Vassey | Zendy; Young Ik Cho | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Compliance With FDA Nicotine Warning Statement Provisions in E-liquid Promotion Posts on Instagram

Author(s) -

Linnea Laestadius,

Megan M. Wahl,

Julia Vassey,

Young Ik Cho

Publication year - 2020

Publication title -

nicotine and tobacco research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.338

H-Index - 113

eISSN - 1469-994X

pISSN - 1462-2203

DOI - 10.1093/ntr/ntaa092

Subject(s) - promotion (chess) , food and drug administration , social media , advertising , nicotine , medicine , business , environmental health , political science , politics , law

Effective August 2018, the U.S. Food and Drug Administration (FDA) required that nicotine addiction warnings be placed on ads for nicotine containing e-liquids. As per FDA comments, this provision pertains to visual ads communicated via social media, raising questions about compliance within the large e-liquid promotion community on Instagram.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research